tachycardia has been produced in unanesthetized dogs by the intravenous injection of ouabain, and the ability of various agents to produce reversion to normal sinus rhythm has been tested. Diphenylhydantoin sodium, procaine amide hydrochloride, procaine hydrochloride and quinidine hydrochloride were approximately equally effective; however the procaine hydrochloride effect was shorter and the drug was more toxic than the other three. It is suggested that diphenylhydantoin sodium may merit a trial for the treatment of digitalis-induced ventricular arrhythmias.
Ventricular tachycardia has been produced in unanesthetized dogs by the intravenous injection of ouabain, and the ability of various agents to produce reversion to normal sinus rhythm has been tested. Diphenylhydantoin sodium, procaine amide hydrochloride, procaine hydrochloride and quinidine hydrochloride were approximately equally effective; however the procaine hydrochloride effect was shorter and the drug was more toxic than the other three. It is suggested that diphenylhydantoin sodium may merit a trial for the treatment of digitalis-induced ventricular arrhythmias.
T-HE TOXIC effects of digitalis compounds have been recognized since the time of Withering' who first described this agent in 1785. Not until the last three decades, however, has progress been made ill the treatment of the toxic cardiac arrhythmias produced by these glycosides. A review has been published by Cohen2 with an extensive bibliography of experimental and clinical attempts to control these arrhythmias. He describes therapeutic efforts centered around the use of (a) parasympatholytic drugs to combat excess vagal tone, (b) electrolytes, chiefly magnesium and potassium, which have been shown to affect the automaticity of heart muscle, and (c) muscle depressants such as qluinidine, procaine, procaine amide, and diethylaminoethanol, which act directly to reduce the irritability and automaticity of the ventricular muscle. Goldberg and Cotten' and Zapata Diaz, Cabrera and M\ndez4 have shown that procaine amide may produce temporary reversion of ouabain or digitoxininduced ventricular tachycardia to normal sinus rhythm. It did not, however, increase the lethal dose of ouabain in cats.'0 From the Department of Pharmacology, Boston University School of Medicine, Boston, Mass. This work was aided yat grant from the Worcester District Chapter of the Massachusetts IHeart Assciation. 65
Central nervous system depressants have been reported to be effective in abolishing ventricular ectopic rhythms. Sabathie5 reported treating 10 cases of ventricular tachycardia (no etiologic data givenii) with morphine sulfate. The effectiveness of certain general anesthetics against experimentally produced toxic digitalis arrhythmias was shown by Mosey and Stutzman. Gold7 suggested that sedatives (barbiturates or bromides) might be used for the treatment of ventricular ectopic beats, although not specifically those caused by digitalis compounds. Making the observation that the tissues of the heart and central nervous system responded to many drugs in similar fashion, Harriss reported that diphenylhydantoin sodium (Dilantin) caused cessation of ectopic activity in dogs with ventricular tachycardia produced by ligating the anterior descending coronary artery. Since that time he has extended his observations, using this preparation to demonstrate the effects of other antiarrhythmic agents.9'10 The present investigation was suggested by the similarity between the ventricular arrhythmias produced by overdosage of ouabain and those produced by ligating the anterior descending coronary artery in dogs. It was felt that if diphenylhydantoin sodium in reasonal)le dlosage provedl effective against ouabaillinduced ventricular tachycardia in clogs, it Circulation, Volume X, July, 195. might offer promise of clinical usefulness in the prevention or treatment of such arrhythmias.
METHODS
Unanesthetized adult mongrel dogs were used in all experiments. The animals were weighed, control electrocardiograms were obtained and 0.08 mg. ouabain per kilogram was injected intrave- nously. An interval of one hour was allowed for the development of the full effect of the drug. If the animals displayed only auriculoventricular block at this dosage, additional ouabain in doses of 0.01 mg. per kilogram was injected at one-half hour intervals until ventricular tachycardia developed. These arrhythmias have been demonstrated to persist from four to six hours in the absence of therapy directed against them.6 The total dosage of ouabain ranged from 0.08 to 0.12 mg. per kilogram.
Five therapeutic regimens were tested in five series of animals prepared with ouabain as described above. Ten control animals received 10 per cent glucose in saline intravenously. The other four series were given drugs at the rate of 5 mg. per kilogram per minute intravenously until the arrhythmia reverted to normal sinus rhythm or prohibitive toxicity developed. In 12 animals infused with diphenylhydantoin sodium, the total dose varied from 10 to 30 mg. per kilogram. Five animals treated with procaine hydrochloride required 15 mg. per kilogram. Eight animals infused with procaine amide hydrochloride received a total dose of 10 to 40 mg. per kilogram. Seven dogs were treated with quinidine hydrochloride in doses of 10 to 40 mg. per kilogram.
Continuous electrocardiographic tracings (lead II) were obtained during the infusions and for two minutes thereafter. The stylus of the direct-writing electrocardiograph was kept under constant observation, and additional tracings were taken at suitable intervals until normal ventricular rhythm reappeared or until the time limit for effects of the cardiac glycoside had passed. The criteria of ventricular tachycardia were those recommended by Katz." The criterion for the effectiveness of the drugs tested for antiarrhythmic activity was complete suppression of ectopic activity, demonstrated by electrocardiogram, and lasting for at least two minutes.
RESULTS
Recurrent emesis, beginning approximately five minutes after the intravenous injection of ouabain, was seen in all animals. The dogs became lethargic and unresponsive, reacting very slightly to handling, as the effects of the cardiac glycoside became more pronounced.
Control infusions of 10 per cent glucose in saline were without effect upon the ventricular tachycardia. One animal died with ventricular fibrillation from the effects of ouabain, 0.08 mg. per kilogram.
The observations made on the 12 animals receiving diphenylhydantoin sodium are presented in table 1. The electrocardiograms of all animals so treated demonstrated complete cessation of ectopic activity. A dosage of 20 mg. per kilogram was selected arbitrarily, and the first six experiments were done using this dosage. It was observed that in some animals the ventricular tachycardia reverted to normal sinus rhythm before the full dose was given. It was decided, therefore, to administer the minimal effective dose required to obtain normal sinus rhythm in each animal. The last six experiments demonstrate the variability of this dose. The heart rate decreased when the pacemaker shifted upward. Second degree heart block was observed in six animals during the period of effectiveness of diphenylhydantoin sodium, and transient nystagmus was seen in one. There was no evidence of central excitation or respiratory stimulation. In 9 of the 12 animals the electrocardiogram showed a return of ventricular ectopic activity two and one half hours later. Emesis recurred immediately before the reappearance of the ectopic beats in these dogs. Two of the remaining three animals vomited two to three hours after the infusion of diphenylhydantoin sodium. All the animals appeared active and responsive in the interval during which normal sinus rhythm was present, in marked contrast to the lethargy following ouabain. Figure 1 is a detailed graph of one experiment (experiment 4) which demonstrates the characteristic response obtained with diphenylhydantoin sodium. Figure 2 shows tracings of representative electrocardiograms taken during this experiment.
The effects of the other three agents, together with those of diphenylhydantoin sodium, upon cardiac rate and rhythm have been summarized in table 2. The infusion of procaine hydrochloride was uniformly successful in reverting the ventricular tachycardia to an auricular rhythm, producing an auricular tachycardia of short duration. One animal developed convulsions and subsequently died following the infusion. The other four dogs manifested central nervous system excitation and tremor. The procaine amide hydrochloride results were similar to those obtained with diphenylhydantoin sodium. Ventricular ectopic activity was abruptly terminated. Second degree auriculoventricular block was observed in two instances. One animal receiving ouabain in a dosage of 0.09 mg. per kilogram developed ventricular tachycardia which terminated in cardiac standstill. Stimulation of the heart by massage through the chest wall resulted in the establishment of a bizarre ventricular arrhythmia. Infusion of 10 mg. of procaine amide hydrochloride per kilogram produced cardiac arrest. The animal was again revived, but died approximately 24 hours later. Electrocardiograms taken before death showed auricular Of the seven animals given quinidine hydrochloride in minimal effective dosage, reversion to sinus rhythm occurred in five. The remaining two animals developed convulsions at dosages All times are minutes from the beginning of the intravenous infusion of the drug. difference in the duration of action of procaine amide hydrochloride, quinidine hydrochloride, or diphenylhydantoin sodium in the dosages used in these experiments.
DISCUSSION AND CONCLUSIONS
The data obtained in this investigation indicate that diphenylhydantoin sodium was effective in dogs in abolishing the ventricular tachycardia resulting from toxic overdosage with ouabain. Procaine hydrochloride, procaine amide hydrochloride and quinidine hydrochloride also proved effective in the treatment of these ventricular arrhythmias. The duration of action of procaine hydrochloride was much shorter than that of the other three agents, thus confirming clinical experience in the use of this drug. Qualitatively similar results were obtained with procaine amide hydrochloride, diphenylhydantoin sodium and quinidine hydrochloride. Procaine hydrochloride seemed to have less effect than the other agents in slowing the heart rate in these experiments.
This difference may be related to the strong central stimulation observed after the infusion of procaine hydrochloride.
Toxic manifestations attributable to diphenylhydantoin sodium were confined to one instance of transient nystagmus. Harriss reported mild emesis immediately after infusion is probably less than that of either procaine hydrochloride or quinidine hydrochloride. The relationship of nausea and vomiting to the cardiac toxicity produced by the cardiac glycosides has been investigated in the past. It has been suggested that emesis is dependent upon a reaction within the heart, which, in turn, reflexly or centrally stimulates vomiting. In the present series of experiments, the emetic effect of ouabain was decreased during the period of diphenylhydantoin sodium activity, and, without exception, vomiting heralded the return of ventricular ectopic activity.
Comparison of the dosage range utilized in these experiments with the dosage employed clinically is presented in table 3. The dosage for diphenylhydantoin sodium was computed on the basis of that tolerated for chronic administration in the control of seizures. The close correlation of the doses used in this study with those employed clinically suggests that the method might be used to evaluate agents for effectiveness against ventricular ectopic activity. SUMMARY Diphenylhydantoin sodium, procaine hydrochloride, procaine amide hydrochloride and quinidine hydrochloride were effective in abolishing the ventricular tachycardia resulting from ouabain overdosage in unanesthetized dogs. Although the effects of these agents were qualitatively similar, procaine hydrochloride was found to have less bradycardic action, shorter duration of effect and greater toxicity than the other three drugs.
The close correlation of the doses found effective in these experiments with the doses used clinically suggests that this method might prove useful in testing new compounds for their effectiveness in counteracting ventricular hyperirritability.
SUMARIO ESPANOL
Difenilhidantoina s6dica, clorhidrato de procalna, clorhidrato de amida procaina y clorhidrato de quinidina fueron efectivos en abolir la taquicardia ventricular resultante de dosis excesiva de ouabalna en perros no anes-tesiados. Aunque los efectos de estos agentes fueron cualitativamente similares, el clorhidrato de procalna se encontr6 tener menos acci6n bradicardica, efecto de duraci6n menor y mayor toxicidad que las otras drogas. La correlaci6n de la dosificaci6n hallada efectiva en estos experimentos con la dosi-ficaci6n usada clinicamente, sugiere, que este m6todo puede probar ser de utilidad en la prueba de compuestos nuevos en cuanto a su eficiencia en contrarrestar la hiperirritabilidad ventricular.
